Claire S Przybyla

Title: Claire S Przybyla: Innovator in Retroviral Protease Inhibitor Development

Introduction

Claire S Przybyla is a prominent inventor based in Des Plaines, IL (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of retroviral protease inhibitors. With a total of 3 patents to her name, Claire's work has the potential to impact the treatment of viral infections.

Latest Patents

One of Claire's latest patents focuses on a method of preparing retroviral protease inhibitor intermediates. This innovative approach involves the use of chiral hydroxyethylamine, hydroxyethylurea, or hydroxyethylsulfonamide isostere containing retroviral protease and renin inhibitors. The method is characterized by multi-step syntheses that utilize key chiral amine intermediates. It is a cost-effective way to obtain these key chiral amine intermediates in an enantiomerically, diastereomerically, and chemically pure form. Furthermore, the method is suitable for large-scale (multikilogram) productions and encompasses organic acid and inorganic acid salts of the amine intermediates.

Career Highlights

Claire is currently associated with G.D. Searle & Company, where she continues to advance her research and development efforts. Her work has been instrumental in creating effective solutions for complex pharmaceutical challenges.

Collaborations

Throughout her career, Claire has collaborated with notable colleagues, including John S Ng and Shu-Hong Zhang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Claire S Przybyla is a dedicated inventor whose work in retroviral protease inhibitors showcases her commitment to advancing medical science. Her innovative methods and collaborative spirit contribute significantly to the field of medicinal chemistry.